Membrane Type 4 Matrix Metalloproteinase (MMP17) Has Tumor Necrosis Factor-α Convertase Activity but Does Not Activate Pro-MMP2
Open Access
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (19), 14046-14055
- https://doi.org/10.1074/jbc.275.19.14046
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Specific Binding of Integrin αvβ3 to the Fibrinogen γ and αE Chain C-Terminal DomainsBiochemistry, 1999
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic ActivationJournal of Biological Chemistry, 1996
- Cell surface binding and activation of gelatinase A induced by expression of membrane‐type‐1‐matrix metalloproteinase (MT1‐MMP)FEBS Letters, 1996
- Degradation of Cross-Linked Fibrin by Matrix Metalloproteinase 3 (Stromelysin 1): Hydrolysis of the γ Gly 404−Ala 405 Peptide BondBiochemistry, 1996
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesTrends in Biotechnology, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991